BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 94 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $147 | -64.2% | 22 | 0.0% | 0.00% | – |
| Q1 2023 | $411 | -79.4% | 22 | -77.1% | 0.00% | – |
| Q1 2022 | $2,000 | -96.7% | 96 | -95.2% | 0.00% | -100.0% |
| Q3 2021 | $61,000 | +306.7% | 2,000 | +300.0% | 0.02% | +433.3% |
| Q2 2021 | $15,000 | -54.5% | 500 | -34.4% | 0.00% | -57.1% |
| Q1 2021 | $33,000 | +266.7% | 762 | +314.1% | 0.01% | +250.0% |
| Q4 2020 | $9,000 | -89.7% | 184 | -90.8% | 0.00% | -91.7% |
| Q3 2020 | $87,000 | – | 2,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 40,000 | $836,000 | 1.01% |
| ACT CAPITAL MANAGEMENT, LLC | 20,000 | $418,000 | 0.44% |
| Knoll Capital Management, LLC | 20,000 | $418,000 | 0.26% |
| Artemis Investment Management LLP | 1,428,228 | $29,855,000 | 0.24% |
| Rubric Capital Management LP | 268,528 | $5,615,000 | 0.20% |
| Virtus ETF Advisers LLC | 7,713 | $161,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 107,700 | $2,252,000 | 0.05% |
| PDT Partners, LLC | 28,031 | $586,000 | 0.05% |
| AllSquare Wealth Management LLC | 3,162 | $66,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 35,221 | $736,000 | 0.04% |